Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing CollaborationBusiness Wire • 03/14/24
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy SummitGlobeNewsWire • 03/13/24
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human UsePRNewsWire • 02/29/24
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to ManufacturingBusiness Wire • 02/21/24
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem CellsBusiness Wire • 02/20/24
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn't Ignore.InvestorPlace • 02/15/24
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call TranscriptSeeking Alpha • 02/14/24
Charles River (CRL) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/14/24
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 GuidanceBusiness Wire • 02/14/24
Unveiling Charles River (CRL) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 02/09/24
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin TestBusiness Wire • 01/29/24
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference CallBusiness Wire • 01/23/24
Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector ManufacturingBusiness Wire • 01/16/24